Innate Pharma S.A. (LON:0EVI)
London · Delayed Price · Currency is GBP · Price in EUR 1.590
-0.024 (-1.49%)
At close: Dec 17, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of 126.8 million as of December 18, 2025. Its market cap has increased by 11.40% in one year.
Market Cap
126.80M
Enterprise Value
97.85M
Revenue
10.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.59
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 126.80M, an increase of 23,800.58%. That is a compound annual growth rate of 33.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 126.80M | -4.13% |
| Dec 31, 2024 | 132.26M | -27.85% |
| Dec 29, 2023 | 183.31M | -21.67% |
| Dec 30, 2022 | 234.02M | -20.77% |
| Dec 31, 2021 | 295.36M | 20.59% |
| Dec 31, 2020 | 244.93M | -38.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.44B |
| HSBC Holdings | 190.63B |
| Shell | 150.64B |
| Unilever | 106.14B |
| Rio Tinto Group | 96.74B |
| British American Tobacco p.l.c. | 93.03B |
| Rolls-Royce Holdings | 91.91B |
| GSK plc | 73.06B |